Sign In
Buy ZEAL
$17.59
+0 (+0%)
At Close: Jan 27, 2023
Zealand Pharma Announces Financial Results for the Full Year 2025
01:00am, Thursday, 19'th Feb 2026
Company announcement – No. 1 / 2026 Zealand Pharma Announces Financial Results for the Full Year 2025 2025 marked a quantum leap for Zealand Pharma, with a transformative partnership for petrelintid
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
01:30am, Wednesday, 18'th Feb 2026
Press release – No. 4 / 2026 Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 Single doses of ZP9830 were well tolerated, with no serious or severe advers
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
11:01am, Thursday, 12'th Feb 2026
Press Release – No. 3 / 2026 Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results Copenhagen, Denmark, February 12, 2026 – Zealand Pharm
Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denm
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
11:05am, Monday, 05'th Jan 2026
Press release - No. 1 / 2026 Zealand Pharma to present at the J. P. Morgan Healthcare Conference Copenhagen, Denmark, January 5, 2026 - Zealand Pharma A/S ("the Company" or "Zealand Pharma") (Nasdaq:
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
11:05am, Wednesday, 31'st Dec 2025
Company announcement – No. 27 / 2025 Total number of shares and voting rights in Zealand Pharma as of December 31, 2025 Copenhagen, Denmark, December 31, 2025 – Zealand Pharma A/S ("the Company" o
Company announcement – No. 26 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenh
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
04:00pm, Thursday, 11'th Dec 2025
Company announcement – No. 25 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, December 11, 2025 – Zealand Pharma A/S (“Zea
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
01:05am, Thursday, 11'th Dec 2025
Press release – No. 19 / 2025 Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health Zealand Pharma targets five launches, +
Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and
Press release – No. 18 / 2025 Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases Collaboration
Company announcement – No. 24 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenh
REMINDER: Zealand Pharma's Capital Markets Day on December 11, 2025
11:00am, Monday, 01'st Dec 2025
Press release – No. 17 / 2025 REMINDER: Zealand Pharma's Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
01:00am, Thursday, 13'th Nov 2025
Company announcement – No. 23 / 2025 Zealand Pharma Announces Financial Results for the First Nine Months of 2025 With petrelintide advancing at full speed and topline data rapidly approaching for b
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
11:30am, Wednesday, 12'th Nov 2025
Press release – No. 16 / 2025 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, November 12, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
